Cargando…

Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity

PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen...

Descripción completa

Detalles Bibliográficos
Autores principales: Call, Mindy, Elzarka, Mohamed, Kunesh, Mary, Hura, Nanki, Birk, David E., Kao, Winston W.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Molecular Vision 2019
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707616/
https://www.ncbi.nlm.nih.gov/pubmed/31523119
_version_ 1783445887700172800
author Call, Mindy
Elzarka, Mohamed
Kunesh, Mary
Hura, Nanki
Birk, David E.
Kao, Winston W.
author_facet Call, Mindy
Elzarka, Mohamed
Kunesh, Mary
Hura, Nanki
Birk, David E.
Kao, Winston W.
author_sort Call, Mindy
collection PubMed
description PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen fibrils that allows for transparency may be disrupted due to genetic mutations and injuries. The purpose of this study is to examine the therapeutic efficacy of human umbilical cord mesenchymal stem/stromal cells (UMSCs) in treating congenital and acquired corneal opacity associated with the loss of collagen V. METHODS: Experimental mice, i.e., wild-type, Col5a1(f/f) and Kera-Cre/Col5a1(f/f) (Col5a1(∆st/∆st), collagen V null in the corneal stroma) mice in a C57BL/6J genetic background, were subjected to a lamellar keratectomy, and treated with or without UMSC (10(4) cells/cornea) transplantation via an intrastromal injection or a fibrin plug. In vivo Heidelberg retinal tomograph (HRT II) confocal microscopy, second harmonic generated (SHG) confocal microscopy, histology, and immunofluorescence microscopy were used to assess the corneal transparency of the regenerated corneas. RESULTS: Col5a1(∆st/∆st) mice display a cloudy cornea phenotype that is ameliorated following intrastromal transplantation of UMSCs. Loss of collagen V in Col5a1(∆st/∆st) corneas augments the formation of cornea scarring following the keratectomy. UMSC transplantation with a fibrin plug improves the healing of injured corneas and regeneration of transparent corneas, as determined with in vivo HRT II confocal microscopy. Second harmonic confocal microscopy revealed the improved collagen fibril lamellar architecture in the UMSC-transplanted cornea in comparison to the control keratectomized corneas. CONCLUSIONS: UMSC transplantation was successful in recovering some corneal transparency in injured corneas of wild-type, Col5a1(f/f) and Col5a1(∆st/∆st) mice. The production of collagen V by transplanted UMSCs may account for the regeneration of corneal transparency, as exemplified by better collagen fiber organization, as revealed with SHG signals.
format Online
Article
Text
id pubmed-6707616
institution National Center for Biotechnology Information
language English
publishDate 2019
publisher Molecular Vision
record_format MEDLINE/PubMed
spelling pubmed-67076162019-09-13 Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity Call, Mindy Elzarka, Mohamed Kunesh, Mary Hura, Nanki Birk, David E. Kao, Winston W. Mol Vis Research Article PURPOSE: Maintenance of a transparent corneal stroma is imperative for proper vision. The corneal stroma is composed of primarily collagen fibrils, small leucine-rich proteoglycans (SLRPs), as well as sparsely distributed cells called keratocytes. The lattice arrangement and spacing of the collagen fibrils that allows for transparency may be disrupted due to genetic mutations and injuries. The purpose of this study is to examine the therapeutic efficacy of human umbilical cord mesenchymal stem/stromal cells (UMSCs) in treating congenital and acquired corneal opacity associated with the loss of collagen V. METHODS: Experimental mice, i.e., wild-type, Col5a1(f/f) and Kera-Cre/Col5a1(f/f) (Col5a1(∆st/∆st), collagen V null in the corneal stroma) mice in a C57BL/6J genetic background, were subjected to a lamellar keratectomy, and treated with or without UMSC (10(4) cells/cornea) transplantation via an intrastromal injection or a fibrin plug. In vivo Heidelberg retinal tomograph (HRT II) confocal microscopy, second harmonic generated (SHG) confocal microscopy, histology, and immunofluorescence microscopy were used to assess the corneal transparency of the regenerated corneas. RESULTS: Col5a1(∆st/∆st) mice display a cloudy cornea phenotype that is ameliorated following intrastromal transplantation of UMSCs. Loss of collagen V in Col5a1(∆st/∆st) corneas augments the formation of cornea scarring following the keratectomy. UMSC transplantation with a fibrin plug improves the healing of injured corneas and regeneration of transparent corneas, as determined with in vivo HRT II confocal microscopy. Second harmonic confocal microscopy revealed the improved collagen fibril lamellar architecture in the UMSC-transplanted cornea in comparison to the control keratectomized corneas. CONCLUSIONS: UMSC transplantation was successful in recovering some corneal transparency in injured corneas of wild-type, Col5a1(f/f) and Col5a1(∆st/∆st) mice. The production of collagen V by transplanted UMSCs may account for the regeneration of corneal transparency, as exemplified by better collagen fiber organization, as revealed with SHG signals. Molecular Vision 2019-08-07 /pmc/articles/PMC6707616/ /pubmed/31523119 Text en Copyright © 2019 Molecular Vision. http://creativecommons.org/licenses/by-nc-nd/3.0/ This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited, used for non-commercial purposes, and is not altered or transformed.
spellingShingle Research Article
Call, Mindy
Elzarka, Mohamed
Kunesh, Mary
Hura, Nanki
Birk, David E.
Kao, Winston W.
Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title_full Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title_fullStr Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title_full_unstemmed Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title_short Therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
title_sort therapeutic efficacy of mesenchymal stem cells for the treatment of congenital and acquired corneal opacity
topic Research Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6707616/
https://www.ncbi.nlm.nih.gov/pubmed/31523119
work_keys_str_mv AT callmindy therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity
AT elzarkamohamed therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity
AT kuneshmary therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity
AT hurananki therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity
AT birkdavide therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity
AT kaowinstonw therapeuticefficacyofmesenchymalstemcellsforthetreatmentofcongenitalandacquiredcornealopacity